Cargando…

A Convenient Truth: Cost of Medications Need Not Be a Barrier to Hepatitis B Treatment

Drugs that are inexpensive to manufacture and simple to administer greatly expand the potential to help tens of millions of people who need treatment for chronic hepatitis B virus (HBV) infection. Key program implementation challenges include identifying who would benefit from antiviral medication a...

Descripción completa

Detalles Bibliográficos
Autor principal: Barnhart, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982244/
https://www.ncbi.nlm.nih.gov/pubmed/27353613
http://dx.doi.org/10.9745/GHSP-D-16-00128

Ejemplares similares